Skip Navigation


Glycobiology Advance Access originally published online on August 25, 2004
Glycobiology 2005 15(1):1-9; doi:10.1093/glycob/cwh132
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
15/1/1    most recent
cwh132v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Joo, E. J.
Right arrow Articles by Kim, Y. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Joo, E. J.
Right arrow Articles by Kim, Y. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Glycobiology vol. 15 no. 1 © Oxford University Press 2005; all rights reserved.

Nucleolin: acharan sulfate–binding protein on the surface of cancer cells

Eun Ji Joo2, Gerdy B. ten Dam3, Toin H. van Kuppevelt3, Toshihiko Toida4, Robert J. Linhardt5 and Yeong Shik Kim1,2

2 Natural Products Research Institute, College of Pharmacy, Seoul National University, 28 Yeonkun-Dong, Jongno-Ku, Seoul 110-460, Korea; 3 Department of Biochemistry, NCMLS, UMC Nijmegen, 6500 HB Nijmegen, The Netherlands; 4 Graduate School of Pharmaceutical Science, Chiba University, Chiba 263-8522, Japan; and 5 Department of Chemistry and Chemical Biology, Biology and Chemical and Biological Engineering, Rensselaer Polytechnic Institute, Troy, NY 12180


1 To whom correspondence should be addressed; e-mail: kims{at}plaza.snu.ac.kr

Received on March 25, 2004; revised on July 19, 2004; accepted on July 22, 2004

Glycosaminoglycans (GAGs) are complex polysaccharides that participate in the regulation of physiological processes through the interactions with a wide variety of proteins. Acharan sulfate (AS), isolated from the giant African snail Achatina fulica, primarily consists of the repeating disaccharide structure {alpha}-D-N-acetylglucosaminyl (1->4) 2-sulfoiduronic acid. Exogenous AS was injected subcutaneously near the tumor tissue in C57BL/6 mice that had been implanted with Lewis lung carcinoma cells (LLCs). The location of AS in the tumor was assessed by staining of sectioned tissues with alcian blue and periodic acid–Schiff (PAS) reagent. In vitro assays indicated binding of cells to 50 µg/ml AS (or heparin) after a 5-h incubation. Immunofluorescence assays, using anti-AS antibody, detected AS at the cell surface. The outer-surface of LLCs were next biotinylated to identify the AS-binding proteins. Biotinylated cells were lysed, and the lysates were fractionated on the AS affinity column using a stepwise salt gradient (0, 0.1, 0.3, 0.5, 0.7, 1.0, and 2.0 M). The fractions were analyzed by SDS–PAGE with silver staining and western blotting. We focused on the proteins with high affinity for AS (eluting at 1 M NaCl) and detected only two bands by western blotting. ESI Q-TOF MS analysis of one of these bands, molecular weight ~110 kDa, showed it to be nucleolin. A phosphorylated form of nucleolin on the surface of cells acts as a cell surface receptor for a variety of ligands, including growth factors (i.e., basic fibroblast growth factor) and chemokines (i.e., midkine). These results show that nucleolin is one of several AS-binding proteins and suggest that AS might demonstrate its tumor growth inhibitory activity by binding the nucleolin receptor protein on the surface of cancer cells.

Key words: AS-binding protein / biotinylation / Lewis lung carcinoma / nucleolin


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Clin PharmacolHome page
R. N. Re and J. L. Cook
The Basis of an Intracrine Pharmacology
J. Clin. Pharmacol., March 1, 2008; 48(3): 344 - 350.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Wittrup, S. Sandgren, J. Lilja, C. Bratt, N. Gustavsson, M. Morgelin, and M. Belting
Identification of Proteins Released by Mammalian Cells That Mediate DNA Internalization through Proteoglycan-dependent Macropinocytosis
J. Biol. Chem., September 21, 2007; 282(38): 27897 - 27904.
[Abstract] [Full Text] [PDF]


Home page
Brief Funct Genomic ProteomicHome page
B. Liu
Exploring cell type-specific internalizing antibodies for targeted delivery of siRNA
Brief Funct Genomic Proteomic, July 31, 2007; (2007) elm015v1.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
C. R. Ireson and L. R. Kelland
Discovery and development of anticancer aptamers
Mol. Cancer Ther., December 1, 2006; 5(12): 2957 - 2962.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.